You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Pulmonology
On demand events

ERS 2022 | Take a Deep Breath: The Evolving Role of Biologics in Pediatric Severe Asthma

Join Prof. Eckard Hamelmann and Dr. Leonard Bacharier as they discuss the evolving role of biologics in pediatric severe asthma.

Eckard Hamelmann
Leonard Bacharier
MD, PhD
Eckard Hamelmann +1 more

On demand materials

ERS 2022 | Take a Deep Breath: The Evolving Role of Biologics in Pediatric Severe Asthma
Pulmonology
expert video

ERS 2022 | Take a Deep Breath: The Evolving Role of Biologics in Pediatric Severe Asthma

ERS 2022 | Inhale: Understanding the True Burden of Pediatric Severe Asthma and Underlying Type 2 Inflammation
Pulmonology
expert video

ERS 2022 | Inhale: Understanding the True Burden of Pediatric Severe Asthma and Underlying Type 2 Inflammation

ERS 2022 | Exhale: Can Biologics Meet the Clinical Needs of Pediatric Asthma Patients?
Pulmonology
expert video

ERS 2022 | Exhale: Can Biologics Meet the Clinical Needs of Pediatric Asthma Patients?

Learning objectives

  • Understand the burden of severe asthma on children and their caregivers and the underlying role of type 2 inflammation in driving the cycle of disease
  • Evaluate the landscape and efficacy data for the approved biologics in pediatric severe asthma
Tags
disease backgroundsymposium

About these experts

Allergy/Immunology
MD, PhD

Eckard Hamelmann

Professor of Pediatrics | Evangelic Hospital, Bielefeld, Germany

Allergy/Immunology
MD

Leonard Bacharier

Janie Robinson and John Moore Lee Chair of Pediatrics and Director of Center for Pediatric Asthma Research | Vanderbilt University, Tennessee, United States

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region